Wilson & Boucher Capital Management’s Quest Diagnostics DGX Stock Holding History

Wilson & Boucher Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Hold	1,200	–	–	0.16%	104
2025 Q4	$208K	Hold	1,200	–	–	0.14%	109
2025 Q3	$229K	Hold	1,200	–	–	0.15%	108
2025 Q2	$216K	Hold	1,200	–	–	0.15%	109
2025 Q1	$203K	Buy	+1,200	New	+$197K	0.15%	106
2024 Q1	–	Sell	-1,500	Closed	-$207K	–	111
2023 Q4	$207K	Buy	+1,500	New	+$197K	0.17%	104
2023 Q3	–	Sell	-1,500	Closed	-$211K	–	104
2023 Q2	$211K	Hold	1,500	–	–	0.19%	102
2023 Q1	$212K	Hold	1,500	–	–	0.2%	101
2022 Q4	$235K	Buy	+1,500	New	+$216K	0.24%	90
2022 Q2	–	Sell	-1,500	Closed	-$205K	–	100
2022 Q1	$205K	Hold	1,500	–	–	0.19%	108
2021 Q4	$260K	Buy	+1,500	New	+$228K	0.23%	93

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Wilson & Boucher Capital Management's DGX Position: Q1 2026 in Review

Wilson & Boucher Capital Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,200 shares worth $235K. The position accounts for 0.16% of the portfolio, ranked #104.

Wilson & Boucher Capital Management first reported a position in DGX in Q4 2021 and has held it in 11 quarters since. The position peaked at $260K in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Wilson & Boucher Capital Management held 1,200 shares of Quest Diagnostics worth $235K as of Q1 2026.
Wilson & Boucher Capital Management left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.16% of Wilson & Boucher Capital Management's portfolio in Q1 2026, its #104 holding.
Wilson & Boucher Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 11 quarters since.
Wilson & Boucher Capital Management's Quest Diagnostics position peaked at $260K in Q4 2021.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q1 2026, filed 18 May 2026.